Methylene Blue

Ingredients of Methylene Blue supplements

Methylene blue is a synthetic chemical compound, not a mixture with multiple ingredients, but a single molecule known as methylthioninium chloride (C16H18ClN3S). Below are the components that define it chemically and how it is typically presented in pharmaceutical or laboratory-grade products.

Chemical Composition

Methylene blue consists of the following elements arranged in a specific molecular structure:

• Carbon (C): 16 atoms
• Hydrogen (H): 18 atoms
• Chlorine (Cl): 1 atom
• Nitrogen (N): 3 atoms
• Sulfur (S): 1 atom

Chemical Formula: C16H18ClN3S

Molar Mass: 319.85 g/mol

Typical Pharmaceutical Presentation

In medical or supplement form (e.g., Heiltropfen Methylene Blue 1% solution), methylene blue is usually provided as:

• Methylthioninium Chloride (Methylene Blue): The active compound, often in a pure, pharma-grade form.
• Water: Used as a solvent to create a solution (e.g., 1% concentration, where 1 g of methylene blue is dissolved in 100 ml of water).

Note: Specific products may include additional stabilizers or preservatives, but these are not standard across all methylene blue preparations and depend on the manufacturer. For example, Heiltropfen’s product lists no additional active ingredients beyond methylene blue and water.

Additional Notes

- Methylene blue is synthesized through a chemical process involving the oxidation of dimethyl-4-phenylenediamine in the presence of sodium thiosulfate, but these are precursors, not ingredients in the final product.
- In compounded formulations (e.g., capsules or injections), inactive ingredients like fillers or pH adjusters (e.g., sodium hydroxide) might be added, but these vary by product and aren’t inherent to methylene blue itself.
- Always check the specific product label for exact ingredients, as formulations can differ (e.g., USP-grade vs. industrial-grade).

Studies regarding the benefits of Methylene Blue

Below is a curated list of peer-reviewed scientific studies exploring the benefits of methylene blue (methylthioninium chloride), a compound with established medical uses and promising investigational applications. These studies cover its effects on methemoglobinemia, neuroprotection, cognitive enhancement, antimicrobial properties, and more, conducted as of March 22, 2025.

1. Treatment of Methemoglobinemia

Study: "Methylene Blue - StatPearls" (Clifton & Leikin, 2023)

• Findings: Methylene blue is FDA-approved for treating methemoglobinemia, converting methemoglobin to hemoglobin via its reduction properties, restoring oxygen-carrying capacity. It’s administered at 1-2 mg/kg IV, with efficacy noted within 30 minutes.
• Source: NCBI Bookshelf
• Significance: This is the primary clinical use, supported by decades of evidence, making it a cornerstone therapy for this condition.

2. Neuroprotection and Cognitive Enhancement

Study: "Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion" (Riha et al., 2011)

• Findings: In rats with chronic cerebral hypoperfusion, daily 4 mg/kg methylene blue attenuated visual learning and memory deficits by enhancing mitochondrial function, suggesting potential for mild cognitive impairment and Alzheimer’s.
• Source: PubMed
• Significance: Highlights methylene blue’s role in improving brain energy metabolism and neuroprotection.

Study: "Methylene blue modulates functional connectivity in the human brain" (Rodriguez et al., 2016)

• Findings: A single 280 mg oral dose in healthy adults increased resting-state functional connectivity in brain regions linked to memory and perception, using fMRI, indicating cognitive enhancement potential.
• Source: PMC
• Significance: First human neuroimaging study showing low-dose effects on brain networks.

3. Anti-Aging and Skin Health

Study: "Anti-Aging Potentials of Methylene Blue for Human Skin Longevity" (Xiong et al., 2017)

• Findings: In human skin fibroblasts and 3D skin models, 100 nM methylene blue stimulated proliferation, delayed senescence, and increased collagen and elastin synthesis, outperforming other antioxidants like NAC.
• Source: Scientific Reports
• Significance: Suggests methylene blue as a promising anti-aging agent for skin care.

4. Antimicrobial Properties

Study: "Photodynamic therapy with methylene blue kills methicillin-resistant Staphylococcus aureus" (Tardivo et al., 2005)

• Findings: Methylene blue, activated by light, effectively killed MRSA in superficial and deep wounds, leveraging its photosensitizing properties.
• Source: PMC
• Significance: Demonstrates its potential as an antimicrobial agent in wound healing.

5. Alzheimer’s Disease and Neurodegeneration

Study: "Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer’s Disease" (Wischik et al., 2015)

• Findings: A methylene blue derivative (Rember, 3×60 mg/day) slowed cognitive decline in Alzheimer’s patients over 1 year by inhibiting tau aggregation, a key pathological feature.
• Source: Journal of Alzheimer’s Disease
• Significance: Provides clinical evidence for methylene blue’s neuroprotective potential in Alzheimer’s.

6. Mitochondrial Function and Oxidative Stress

Study: "Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways" (Atamna et al., 2008)

• Findings: Low-dose methylene blue delayed cellular senescence in fibroblasts by enhancing mitochondrial cytochrome c oxidase activity and reducing oxidative stress.
• Source: FASEB Journal
• Significance: Underpins its role in cellular energy production and anti-aging.

Notes

• Established Use: Methemoglobinemia treatment is the only FDA-approved use, with robust clinical backing.
• Investigational Benefits: Cognitive enhancement, neuroprotection, anti-aging, and antimicrobial effects are supported by preclinical and early clinical studies but require larger trials for confirmation.
• Caution: Benefits beyond methemoglobinemia should be explored under medical supervision due to potential side effects (e.g., serotonin syndrome at high doses) and limited regulatory approval.